Preferred Label : antibodies, heterophile;
MeSH definition : Antibodies elicited in a different species from which the antigen originated. These
antibodies are directed against a wide variety of interspecies-specific antigens,
the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell
(P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile
antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of
infection and latent infectious states as well as in cancer classification.;
MeSH synonym : xenogeneic antibodies; antibodies, xenogenic; antibodies, heterologous; heterogenetic antibodies; heterotypic antibodies; antibodies, heterotypic; antibodies, heterophil; heterophile antibodies; heteroantibodies; antibodies, heterogenetic; heterophil antibodies; antibodies, xenogeneic; heterologous antibodies; xenogenic antibodies; xenoantibodies;
MeSH hyponym : Hanganutziu-Deicher antibodies; Paul-Bunnell antibodies; forssman antibody; H-D Antibodies; P-B Antibodies; Antibody, Forssman;
MeSH annotation : do not coordinate with ANTIBODY FORMATION for /biosyn;
Wikipedia link : https://en.wikipedia.org/wiki/Antibodies, heterophile;
Is substance : O;
Origin ID : D000910;
UMLS CUI : C0003248;
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- XAV-19 [MeSH Supplementary Concept]
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Antibodies elicited in a different species from which the antigen originated. These
antibodies are directed against a wide variety of interspecies-specific antigens,
the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell
(P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile
antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of
infection and latent infectious states as well as in cancer classification.
https://www.has-sante.fr/jcms/p_3312591/fr/xav-19-immunoglobuline-g-porcine-anti-sars-cov-2
https://www.has-sante.fr/jcms/p_3312597/fr/decision-n-2022-0029/dc/sem-du-27-janvier-2022-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-autorisation-d-acces-precoce-de-la-specialite-xav-19
2022
false
false
false
France
Anti-SARS-CoV-2 Polyclonal Antibodies XAV-19
COVID-19
antibodies, heterophile
SARS Coronavirus 2 Antibody
insurance, health, reimbursement
treatment outcome
oxygen inhalation therapy
infusions, intravenous
evaluation of the transparency committee
SARS-CoV-2
XAV-19
---